139 related articles for article (PubMed ID: 38441194)
1. Molecular and nutritional markers in head and neck cancer.
Milano G; Gal J; Bensadoun RJ
Curr Opin Oncol; 2024 May; 36(3):123-127. PubMed ID: 38441194
[TBL] [Abstract][Full Text] [Related]
2. Monitoring of circulating tumor cells and their expression of EGFR/phospho-EGFR during combined radiotherapy regimens in locally advanced squamous cell carcinoma of the head and neck.
Tinhofer I; Hristozova T; Stromberger C; Keilhoiz U; Budach V
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e685-90. PubMed ID: 22583603
[TBL] [Abstract][Full Text] [Related]
3. The presence of circulating tumor cells (CTCs) correlates with lymph node metastasis in nonresectable squamous cell carcinoma of the head and neck region (SCCHN).
Hristozova T; Konschak R; Stromberger C; Fusi A; Liu Z; Weichert W; Stenzinger A; Budach V; Keilholz U; Tinhofer I
Ann Oncol; 2011 Aug; 22(8):1878-85. PubMed ID: 21525401
[TBL] [Abstract][Full Text] [Related]
4. The association between EGFR variant III, HPV, p16, c-MET, EGFR gene copy number and response to EGFR inhibitors in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Chau NG; Perez-Ordonez B; Zhang K; Pham NA; Ho J; Zhang T; Ludkovski O; Wang L; Chen EX; Tsao MS; Kamel-Reid S; Siu LL
Head Neck Oncol; 2011 Feb; 3():11. PubMed ID: 21352589
[TBL] [Abstract][Full Text] [Related]
5. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers.
Hristozova T; Konschak R; Budach V; Tinhofer I
Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of circulating tumor cells in patients with squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.
Wang Z; Cui K; Xue Y; Tong F; Li S
Med Oncol; 2015 May; 32(5):164. PubMed ID: 25895596
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance].
Ma L; Wang D; Wufuer A; Wu R; Zhang S; Wang R
Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):23-8. PubMed ID: 24685082
[TBL] [Abstract][Full Text] [Related]
8. Biology and patterns of response to EGFR-inhibition in squamous cell cancers of the lung and head & neck.
Juergens RA; Bratman SV; Tsao MS; Laurie SA; Sara Kuruvilla M; Razak AR; Hansen AR
Cancer Treat Rev; 2017 Mar; 54():43-57. PubMed ID: 28192747
[TBL] [Abstract][Full Text] [Related]
9. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
10. p16, HPV, and Cetuximab: What Is the Evidence?
Bonner JA; Mesia R; Giralt J; Psyrri A; Keilholz U; Rosenthal DI; Beier F; Schulten J; Vermorken JB
Oncologist; 2017 Jul; 22(7):811-822. PubMed ID: 28526718
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
[TBL] [Abstract][Full Text] [Related]
12. Current applications and challenges of circulating tumor DNA (ctDNA) in squamous cell carcinoma of the head and neck (SCCHN).
Galot R; Machiels JH
Cancer Treat Rev; 2020 Apr; 85():101992. PubMed ID: 32092618
[TBL] [Abstract][Full Text] [Related]
13. Multiparameter analysis, including EMT markers, on negatively enriched blood samples from patients with squamous cell carcinoma of the head and neck.
Balasubramanian P; Lang JC; Jatana KR; Miller B; Ozer E; Old M; Schuller DE; Agrawal A; Teknos TN; Summers TA; Lustberg MB; Zborowski M; Chalmers JJ
PLoS One; 2012; 7(7):e42048. PubMed ID: 22844540
[TBL] [Abstract][Full Text] [Related]
14. Nuclear epidermal growth factor receptor and p16 expression in head and neck squamous cell carcinoma.
Husain H; Psyrri A; Markovic A; Rampias T; Pectasides E; Wang H; Slebos R; Yarbrough WG; Burtness B; Chung CH
Laryngoscope; 2012 Dec; 122(12):2762-8. PubMed ID: 23086695
[TBL] [Abstract][Full Text] [Related]
15. Molecular profile of head and neck squamous cell carcinomas bearing p16 high phenotype.
Rampias T; Pectasides E; Prasad M; Sasaki C; Gouveris P; Dimou A; Kountourakis P; Perisanidis C; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A
Ann Oncol; 2013 Aug; 24(8):2124-31. PubMed ID: 23406730
[TBL] [Abstract][Full Text] [Related]
16. Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
Zhang H; Kim S; Chen Z; Nannapaneni S; Chen AY; Moore CE; Sica G; Mosunjac M; Nguyen MLT; D'Souza G; Carey TE; Peterson LA; McHugh JB; Graham M; Komarck CM; Wolf GT; Walline HM; Bellile E; Riddell J; Pai SI; Sidransky D; Westra WH; William WN; Lee JJ; El-Naggar AK; Ferris RL; Seethala R; Grandis JR; Chen ZG; Saba NF; Shin DM;
Head Neck; 2017 Dec; 39(12):2433-2443. PubMed ID: 28945296
[TBL] [Abstract][Full Text] [Related]
17. Exploring biomarkers in head and neck cancer.
Langer CJ
Cancer; 2012 Aug; 118(16):3882-92. PubMed ID: 22281752
[TBL] [Abstract][Full Text] [Related]
18. Molecular phenotypes of circulating tumor cells and efficacy of nivolumab treatment in patients with head and neck squamous cell carcinoma.
Tada H; Takahashi H; Kawabata-Iwakawa R; Nagata Y; Uchida M; Shino M; Ida S; Mito I; Matsuyama T; Chikamatsu K
Sci Rep; 2020 Dec; 10(1):21573. PubMed ID: 33299117
[TBL] [Abstract][Full Text] [Related]
19. Translational Research: A Future Strategy for Managing Squamous Cell Carcinoma of the Head and Neck?
Caponigro F; Ionna F; Scarpati GDV; Longo F; Addeo R; Manzo R; Muto P; Pisconti S; Leopaldi L; Perri F
Anticancer Agents Med Chem; 2018; 18(9):1220-1227. PubMed ID: 29637868
[TBL] [Abstract][Full Text] [Related]
20. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
